## Abstract ## Objective We sought to explore bladder dysfunction in a cohort of women with systemic lupus erythematosus (SLE). ## Methods We conducted a prospective study of 152 female patients with SLE during a 15‐month period. The clinical status of SLE was determined according to the SLE Dis
Salivary testosterone levels in women with systemic lupus erythematosus
✍ Scribed by Miguel A. Navarro; Antonio Vidaller; Juan B. Ortolá; Maria R. Bonnin; Maria V. Pac; Isabel Moga
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 197 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
✦ Synopsis
Objective. To measure salivary testosterone in women with systemic lupus erythematosus (SLE).
Methods. We investigated concentrations of salivary testosterone in 13 women with active SLE and 47 women with inactive SLE, and in 72 healthy female controls.
Results. We found a significant decrease in salivary testosterone concentrations in glucocorticoidtreated SLE patients (mean 2 SD 0.06 f 0.04 nmoled liter) but no differences in concentrations in untreated patients (0.09 f 0.03 nmolesfiiter), compared with the healthy controls (0.11 f 0.04 nmoleshiter).
Conclusion. Glucocorticoid treatment appears to cause a decrease in the salivary testosterone level. Measurement of salivary testosterone is a simple way of monitoring androgen metabolism in patients with SLE.
📜 SIMILAR VOLUMES
Maternal serum inhibin A levels are increased on average in pregnancies affected by Down syndrome (DS). However, some reports have found increased serum levels in women with pre-eclamptic toxaemia as well. In the current study, maternal serum inhibin A was retrospectively measured in a series of 32